INTECH Investment Management’s Teladoc Health TDOC Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q2
$358K Buy
42,224
+3,166
+8% +$21.1K ﹤0.01% 1490
2026
Q1
$213K Sell
39,058
-22,423
-36% -$126K ﹤0.01% 1728
2025
Q4
$430K Hold
61,481
﹤0.01% 1584
2025
Q3
$475K Sell
61,481
-31,353
-34% -$245K ﹤0.01% 1603
2025
Q2
$809K Sell
92,834
-23,445
-20% -$170K 0.01% 1332
2025
Q1
$926K Buy
116,279
+55,386
+91% +$560K 0.01% 1241
2024
Q4
$554K Buy
60,893
+27,174
+81% +$262K 0.01% 1501
2024
Q3
$310K Buy
+33,719
New +$279K ﹤0.01% 1502
2022
Q3
Sell
-7,265
Closed -$241K 681
2022
Q2
$241K Buy
+7,265
New +$309K ﹤0.01% 654

Other funds holding TDOC

INTECH Investment Management's TDOC Position: Q2 2026 in Review

INTECH Investment Management increased its Teladoc Health (TDOC) stake by 8.1% in Q2 2026, buying an estimated $21.1K and bringing the position to 42,224 shares worth $358K. The position accounts for ﹤0.01% of the portfolio, ranked #1490.

INTECH Investment Management first reported a position in TDOC in Q2 2022 and has held it in 9 quarters since. The position peaked at $926K in Q1 2025. 347 funds tracked by Wall St. Rank hold TDOC as of Q2 2026.

  • INTECH Investment Management held 42,224 shares of Teladoc Health worth $358K as of Q2 2026.
  • INTECH Investment Management bought 3,166 Teladoc Health shares in Q2 2026, an estimated $21.1K.
  • Teladoc Health made up ﹤0.01% of INTECH Investment Management's portfolio in Q2 2026, its #1490 holding.
  • INTECH Investment Management first reported a position in Teladoc Health in Q2 2022 and has held it in 9 quarters since.
  • INTECH Investment Management's Teladoc Health position peaked at $926K in Q1 2025.
  • 347 funds tracked by Wall St. Rank held Teladoc Health as of Q2 2026.

Based on INTECH Investment Management's 13F filing for Q2 2026, filed 10 Aug 2026.